Sniffing (drug use)

This article or the following section is not adequately provided with supporting documents ( e.g. individual evidence ). Information without sufficient evidence could be removed soon. Please help Wikipedia by researching the information and including good evidence.

As sniffing which is abusive use of volatile industrial solvents of different chemical structure, respectively. These “ sniff substances ” are mainly gasoline , acetone , toluene , trichlorethylene and fluorocarbons . In the ICD-10 , the resulting disorders are summarized under F.18.

Compared to the other addictive substances , there is a special feature here: These substances are not intended for human use. Rather, they serve to prepare certain chemical materials such as paints, adhesives, rubber and cosmetics for easier processing. The solvents are produced in chemical industrial processes and are characterized by an intense characteristic odor and high volatility. This means that the air above the medium is enriched with the vapor of these substances.

Legal position

Since the substances mentioned do not fall under the Narcotics Act ( BtMG ) in Germany , there are no precise statistics on the prevalence and number of "sniffing". However, the substances mentioned fall under the definition of Section 2 (1) of the German Medicines Act ( AMG ) as soon as they are intended for use on humans or animals. The production and sale of a substance is therefore regulated by the AMG, regardless of the form in which the substance is present, if it complies with Section 2 (1). The sale and manufacture of pharmaceuticals without a license is punishable under AMG § 2 Paragraph 1 No. 5 a. F., § 2 Paragraph 1 No. 2a new version, § 5, § 95 Paragraph 1 No. 1, StPO § 354a. This was confirmed in a ruling by the Federal Court of Justice on the freely available chemical γ-butyrolactone ( GBL ), which is classified as a medicinal product according to the AMG as soon as it is intended for consumption or use on humans or animals.

Individual evidence

1. ^ Erwin Deutsch, Rudolf Ratzel, Hans-Dieter Lippert: Commentary on the Medicines Act (AMG). 3rd edition, Gabler Wissenschaftsverlage, 2010, ISBN 978-3-6420-1454-3 , pp. 64–66 ( limited preview in the Google book search).
2. ↑ ArzneimittelG, Section 2, Paragraph 1, No. 5 a. F., Section 2 Paragraph 1 No. 2a new version, Section 5, Section 95 Paragraph 1 No. 1. Accessed on May 16, 2012.
3. ↑ Martin Kämpf: Criminal Law: Trading with gamma-butyrolactone (GBL, liquid ecstasy) for consumption purposes. July 25, 2011.
4. ↑ The unauthorized placing on the market of gamma-butyrolactone (GBL) for consumption purposes is punishable under the Medicines Act. BGH judgment of December 8, 2009, 1 StR 277/09, LG Nürnberg-Fürth at Lexetius.com/2009,3836.